Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Stifel GMP Presentation

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Dec 09, 2021 12:52pm

73 Views

Post# 34215054

RE:RE:RE:Stifel GMP Presentation

I agre Candy, they were fast, smart and opportunistic with the PP at $10. Later they were too slow and failled in the lost cause of adventurism in LATAM while they ignored many opportunities in developped markets. Thus MNGT and BDO are only delaying the inevitable to resighn

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec